Page 172 - பல்கலைக்கழகம் ஆஃப் நாட்டிங்ஹாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19: First nationwide data from Israel shows 95% protection from infection after two doses of Pfizer jab

Live and Local Podcast - Supporting Live Local Music On The Isle Of Wight COVID-19: First nationwide data from Israel shows 95% protection from infection after two doses of Pfizer jab Two doses of Pfizer s COVID-19 vaccine can provide more than 95% protection against infection, severe illness, and death, according to the first nationwide data from Israel. A single dose of the jab, meanwhile, is associated with 58% protection against infection, 76% against hospital admission, and 77% against death, research published in The Lancet suggests. The study uses Israeli ministry of health data from between 24 January and 3 April this year, a time when the UK variant was responsible for most of the country s infections.

United kingdomLuis jodarSharon alroy preisJonathan ballUniversity of nottinghamSky newsஒன்றுபட்டது கிஂக்டம்ஷரோன் அல்ராய் ப்ரேச்ஜொனாதன் பந்துபல்கலைக்கழகம் ஆஃப் நாட்டிங்ஹாம்வானம் செய்தி

English University Receives Funding to Advance Aerospace Ceramic Coating

Photo Credit: University of Nottingham A materials expert at the University of Nottingham (Nottingham, England) has secured over £2.1m to develop new coatings for use in aerospace that could cut jet plane CO 2 emissions and help spacecraft built for humans venture further into our solar system. Dr. Tanvir Hussain, of the university, has received the five-year fellowship funded by the Engineering and Physical Sciences Research Council to find new modeling and processing techniques that will overhaul the design and manufacture of advanced ceramic materials for the next generation of air and space travel. Dr. Hussain, from the Coatings and Surface Engineering Research group, explains, “Ceramics are an important group of materials and their processing into aerospace coatings and components requires specialist techniques. Current approaches for new materials discovery and production are wasteful, costly and energy inefficient.”

Tanvir hussainUniversity of nottinghamSciences research councilPhysical sciences research councilSurface engineeringArtificial intelligenceதன்வீர் ஹுசைன்பல்கலைக்கழகம் ஆஃப் நாட்டிங்ஹாம்அறிவியல் ஆராய்ச்சி சபைஉடல் அறிவியல் ஆராய்ச்சி சபைமேற்பரப்பு பொறியியல்செயற்கை உளவுத்துறை

Two doses of Pfizer vaccine effective against Covid-19 infection, illness, and death

Two doses of Pfizer vaccine effective against Covid-19 infection, illness, and death
somersetlive.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from somersetlive.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomLuis jodarSharon alroy preisJonathan ballUniversity of nottinghamUk world newsஒன்றுபட்டது கிஂக்டம்ஷரோன் அல்ராய் ப்ரேச்ஜொனாதன் பந்துபல்கலைக்கழகம் ஆஃப் நாட்டிங்ஹாம்இங்கிலாந்து உலகம் செய்தி

EMB 23 30: Pfizer vaccine 95% effective against coronavirus, real-world data from Israel shows

Two doses of the Pfizer-BioNTech vaccine can provide more than 95 per cent protection against infection, severe illness and death from Covid, according to a groundbreaking study in Israel. The middle eastern country currently leads the world in its inoculation programme, with more than half (56 per cent) of its population having already received both doses of the Pfizer vaccine. Back in January, Israel’s prime minister Benjamin Netanyahu struck.

United kingdomLuis jodarBenjamin netanyahuSharon alroy preisJonathan ballUniversity of nottinghamGetty imagesஒன்றுபட்டது கிஂக்டம்ஷரோன் அல்ராய் ப்ரேச்ஜொனாதன் பந்துபல்கலைக்கழகம் ஆஃப் நாட்டிங்ஹாம்கெட்டி படங்கள்

Evotec launches beLAB1407 to accelerate translational research from the UK s academic life science

Search jobs 06-May-2021 Evotec launches beLAB1407 to accelerate translational research from the UK s academic life science ecosystem in collaboration with Bristol Myers Squibb DGAP-News: Evotec SE / Key word(s): Miscellaneous 06.05.2021 / 07:30 beLAB1407 TRANSLATES ACADEMIC INNOVATION FROM LEADING ACADEMIC INSTITUTIONS IN THE UK THE COLLABORATION LEVERAGES EVOTEC S UNIQUE MULTIMODALITY PLATFORM TO VALIDATE FIRST-IN-CLASS THERAPEUTIC CONCEPTS FROM THE UNIVERSITIES OF BIRMINGHAM, EDINBURGH, NOTTINGHAM, AND DUNDEE BRISTOL MYERS SQUIBB JOINS beLAB1407 AS A BIOPHARMA COLLABORATOR Hamburg, Germany, 06 May 2021: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that the Company, together with Bristol-Myers Squibb Company (NYSE: BMY), has launched beLAB1407, a new $ 20 m academic BRIDGE to identify and advance novel and breakthrough drug discovery opportunities across therapeutic areas from

United statesUnited kingdomCity ofGreat britainAndrew naylorGeorge baxterWerner lanthalerDavid mcbethThomas hankeVolker braunRupert vesseyDavid colemanGabriele hansenInnovation development generation efficiencyUniversity of birmingham enterpriseBoehringer ingelheim